Abstract
A method of assessing chemosensitivity of tissue utilizing tissue fluorescence and image analysis was implemented to provide a rapid and quantitative means of assessing the effect of drugs on tissue metabolic activity and proliferative capacity. The fluorescent microscopic image captured by a silicon-intensified target (low-light-detecting) camera and linked to an imageprocessing unit was measured for fluorescent brightness and tumor image area. An established rodent model served to characterize the system's ability to measure serially the tumor's metabolic activity and growth. Further studies on fresh human tumors were conducted with a novel topoisomerase II inhibitor, NC-190. Tumor image area and fluorescent brightness were measured 24 h pretreatment, 48 h posttreatment, and 48 h post-drug removal. Fifty-five percent (28/51) of fresh human tumors showed sensitivity to 48-h exposure to 10, 30, or 100 MNC-190. The potential benefit of this technique is the ability to predict the response of tumors to chemotherapeutic agents as a laboratory tool for preclinical drug evaluation and clinically prior to the commencement of therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rotman, B., Teplitz, C., Dickinson, K., and Cozzolino, J. P. (1988) Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting. In Vitro Cell Dev. Biol. 24(11), 1137–1146.
Leone, L. A., Meitner, P. A., Myers, T. J., et al. (1991) Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy. Cancer Invest. 9(5), 491–503.
Meitner, P. A. (1991) The fluorescent cytoprint assay: a new approach to in vitro chemosensitivity testing. Oncology 5(9), 75–88.
Rotman, B. and Papermaster, B. W. (1996) Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc. Natl. Acad. Sci. USA 55, 134–141.
Gibbs, J. F., Slocum, H. K., Cao, S., and Rustum, Y. M. (1999) Image analysis for quantitation of solid tumor drug sensitivity. Int. J. Surg. Invest. 1, 133–138.
Nakaike, S., Yamagishi, T., Samata, K., et al. (1989) In vitro activity on murine tumors of a novel antitumor compound, N-/sB-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190). Cancer Chemother. Pharmacol. 23, 135–139.
Tsuruo, T., Naito, M., Takamori, R., et al. (1990) A benzophenazine derivative, N-ß-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo [a]phenazine-6-carboxamide, as a new antitumor agent against multidrug-resistant and sensitive tumors. Cancer Chemother. Pharmacol. 26, 83–87.
Slocum, H. K., Malmberg, M., Greco, W. R., Parsons, J.C., and Rustum, Y. M. (1990) The determination of growth rates of individual colonies in agarose using high-resolution automated image analysis. Cytometry 11, 793–804.
Ward, J. M., Yamamoto, R. S., Weisburger, J. H., and Benjamin, T.(1973) Transplantation of chemically induced metastatic mucinous adenocarcinomas of the jejunum and colon in rats. J. Natl. Cancer Inst. 51(6), 1993–1995.
Rustum, Y. M., Liu, L., and Zhang, Z.(1988) Role of dose, schedule, and route of administration of 5-formyltetrahydrofolate: preclinical and clinical investigations, in The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy, vol. 244 (Rustum, Y. and McGuire, J. eds.), Plenum, New York, pp. 39–52.
Danhauser, L.L. and Rustum, Y. M. (1987) Potential for selective enhancement of the in vivo metabolism of 1-B-D-arabinofuranosylcytosine in rats by thymidine pretreatment. Cancer Res. 45, 2002–2007.
Danhauser, L.L. and Rustum, Y.M. (1984) Chemotherapeutic efficacy of 5-fluorouracil with concurrent thymidine infusion against transplantable colon tumors in rodents. Cancer Drug Deliv. 1(4), 269–282.
Lai-Sim Au, J., Walker, J. S., and Rustum, Y. (1983) Pharmacokinetic studies of 5-fluorouracil and 5-deoxy-5-fluorouridine in rats. J. Pharm. Exp. Ther. 227(1), 174–180.
Gibbs, J. F., Slocum, H. K., Reska, N., Winslow, E., Frank, C. and Rustum, Y. M. (1994) In vitro activity of a novel chemotherapeutic agent, N-ß-dimethylaminoethyl-O-carboxy-5-hydroxy-10-methoxybenzo [a] phenazine-6-carboxamide (NC-190), against human tumors. Proc. Am. Assoc. Cancer Res. 35, A2405.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
F.Gibbs, J., M.Rustum, Y., K.Slocum, H. (2005). Image Analysis Using the Fluorochromasia Assay to Quantify Tumor Drug Sensitivity. In: Blumenthal, R.D. (eds) Chemosensitivity. Methods in Molecular Medicine™, vol 110. Humana Press. https://doi.org/10.1385/1-59259-869-2:185
Download citation
DOI: https://doi.org/10.1385/1-59259-869-2:185
Publisher Name: Humana Press
Print ISBN: 978-1-58829-345-9
Online ISBN: 978-1-59259-869-4
eBook Packages: Springer Protocols